Literature DB >> 15587945

Genetics and drug use as a complex phenotype.

Christina N Lessov1, Gary E Swan, Huijun Z Ring, Taline V Khroyan, Caryn Lerman.   

Abstract

Drug use is a complex behavior influenced by multiple biological, family, and sociocultural factors. The concurrent use/misuse of multiple drugs is often seen and drug use also co-occurs with other psychiatric conditions. Behavior and molecular genetic studies support an important posited role of genes in drug use. This posited genetic risk does not appear to be conferred by one or two major genes manifesting large effects, but rather by a number of genes manifesting smaller effects. Genetic factors explain, on average, only about half of the total variability in drug use, with the remaining variability influenced by environmental factors. Also, genetic risk may be differentially expressed in the presence vs. absence of particular environmental conditions. Thus, investigation of environmental factors and their interaction with genetic risk is a necessary component of genetic research. While the full potential of genetic investigations for the prevention of drug misuse has yet to be realized, an example of the impact of risk factor modification under various conditions of gene-environment interaction is provided, and the implications for use of genetic information in drug-misuse prevention are discussed. The multifactorial nature of drug use necessitates coordinated investigation from multiple disciplines and timely dissemination of scientific findings. In addition, this work demands adherence to the highest standards of confidentiality and ethical use of genetic information to best inform future prevention efforts.

Entities:  

Mesh:

Year:  2004        PMID: 15587945     DOI: 10.1081/ja-200033202

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  16 in total

1.  Sober housing and motivational interviewing: the Treatment Access Project.

Authors:  Deborah Fisk; Dave Sells; Michael Rowe
Journal:  J Prim Prev       Date:  2007-06-06

2.  Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity.

Authors:  Agnieszka Gieryk; Barbara Ziolkowska; Wojciech Solecki; Jakub Kubik; Ryszard Przewlocki
Journal:  Psychopharmacology (Berl)       Date:  2009-12-09       Impact factor: 4.530

3.  Substance use disorder genetic research: investigators and participants grapple with the ethical issues.

Authors:  Marilyn E Coors; Kristen M Raymond
Journal:  Psychiatr Genet       Date:  2009-04       Impact factor: 2.458

Review 4.  Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.

Authors:  Ruthie E Wittenberg; Shannon L Wolfman; Mariella De Biasi; John A Dani
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

Review 5.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

Review 6.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

Review 7.  Genetics of nicotine dependence and pharmacotherapy.

Authors:  Christina N Lessov-Schlaggar; Michele L Pergadia; Taline V Khroyan; Gary E Swan
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

8.  Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation.

Authors:  Ju Wang; Ming D Li
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

9.  Nine generations of selection for high and low nicotine intake in outbred Sprague-Dawley rats.

Authors:  Tanseli Nesil; Lutfiye Kanit; Ming D Li; Sakire Pogun
Journal:  Behav Genet       Date:  2013-08-04       Impact factor: 2.805

10.  Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes.

Authors:  Timothy B Baker; Robert B Weiss; Daniel Bolt; Andrew von Niederhausern; Michael C Fiore; Diane M Dunn; Megan E Piper; Nori Matsunami; Stevens S Smith; Hilary Coon; William M McMahon; Mary B Scholand; Nanda Singh; John R Hoidal; Su-Young Kim; Mark F Leppert; Dale S Cannon
Journal:  Nicotine Tob Res       Date:  2009-05-12       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.